313 filings
Page 2 of 16
SC 13G
APRE
Aprea Therapeutics Inc
14 Feb 24
Aprea Therapeutics / Sio Capital Management ownership change
8:00am
424B3
APRE
Aprea Therapeutics Inc
9 Feb 24
Prospectus supplement
12:00am
SC 13G/A
APRE
Aprea Therapeutics Inc
7 Feb 24
Aprea Therapeutics / HIRSCHMAN ORIN ownership change
6:55pm
8-K
APRE
Aprea Therapeutics Inc
6 Feb 24
Other Events
5:01pm
EFFECT
APRE
Aprea Therapeutics Inc
5 Feb 24
Notice of effectiveness
12:15am
424B3
APRE
Aprea Therapeutics Inc
5 Feb 24
Prospectus supplement
12:00am
8-K
APRE
Aprea Therapeutics Inc
2 Feb 24
Results of Operations and Financial Condition
4:26pm
CORRESP
APRE
Aprea Therapeutics Inc
31 Jan 24
Correspondence with SEC
12:00am
UPLOAD
APRE
Aprea Therapeutics Inc
30 Jan 24
Letter from SEC
12:00am
8-K
APRE
Aprea Therapeutics Inc
26 Jan 24
Entry into a Material Definitive Agreement
7:13am
S-3
APRE
Aprea Therapeutics Inc
Shelf registration
26 Jan 24
6:03am
8-K
APRE
Aprea Therapeutics Inc
4 Jan 24
Aprea Therapeutics Provides Corporate Update and Announces Development Plans for 2024
4:16pm
S-8
APRE
Aprea Therapeutics Inc
9 Nov 23
Registration of securities for employees
4:20pm
8-K
APRE
Aprea Therapeutics Inc
9 Nov 23
Aprea Therapeutics Reports Third Quarter 2023 Financial Results and Provides a Business Update
4:15pm
10-Q
2023 Q3
APRE
Aprea Therapeutics Inc
Quarterly report
9 Nov 23
4:10pm
8-K
APRE
Aprea Therapeutics Inc
16 Oct 23
Other Events
5:29pm
8-K
APRE
Aprea Therapeutics Inc
13 Oct 23
Other Events
7:31am
8-K
APRE
Aprea Therapeutics Inc
11 Sep 23
Other Events
8:30am
4
Rifat Pamukcu
24 Aug 23
Aprea Therapeutics / Rifat Pamukcu ownership change
9:52pm
4
Grissinger Michael
24 Aug 23
Aprea Therapeutics / Michael Grissinger ownership change
9:51pm